Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Gary Berman"'
Autor:
Amparo L. Figueroa, Kashif Ali, Gary Berman, Honghong Zhou, Weiping Deng, Wenqin Xu, Stephanie Lussier, Bethany Girard, Frank J. Dutko, Karen Slobod, Anne Yeakey, Frances Priddy, Jacqueline M. Miller, Rituparna Das
Publikováno v:
EClinicalMedicine, Vol 74, Iss , Pp 102720- (2024)
Summary: Background: Longitudinal changes in vaccination-induced immune response remain inadequately characterized in adolescents. We present long-term safety, immunogenicity, and COVID-19 incidence following a 2-dose mRNA-1273 100-μg primary series
Externí odkaz:
https://doaj.org/article/6f2192f297bc4ef6ab25ef446fac3250
Autor:
Evan J, Anderson, C Buddy, Creech, Vladimir, Berthaud, Arin, Piramzadian, Kimball A, Johnson, Marcus, Zervos, Fredric, Garner, Carl, Griffin, Khozema, Palanpurwala, Mark, Turner, Jeffrey, Gerber, Richard L, Bennett, Kashif, Ali, Madhavi, Ampajwala, Gary, Berman, Jennifer, Nayak, Carey, Chronis, Barbara, Rizzardi, William J, Muller, Christopher A, Smith, George, Fuchs, Daniel, Hsia, Joanne E, Tomassini, Dianne, DeLucia, Caroline, Reuter, Barbara, Kuter, Xiaoping, Zhao, Weiping, Deng, Honghong, Zhou, Daniela, Ramirez Schrempp, Kelly, Hautzinger, Bethany, Girard, Karen, Slobod, Roderick, McPhee, Rolando, Pajon, Anne, Aunins, Rituparna, Das, Jacqueline M, Miller, Sabine, Schnyder Ghamloush, Yamna, Ali
Publikováno v:
The New England journal of medicine. 387(18)
The safety, reactogenicity, immunogenicity, and efficacy of the mRNA-1273 coronavirus disease 2019 (Covid-19) vaccine in young children are unknown.Part 1 of this ongoing phase 2-3 trial was open label for dose selection; part 2 was an observer-blind
Autor:
Weiping Deng, William Hillebrand, Jacqueline Dooley, Veronica Faughnan, Bethany Girard, Roderick McPhee, Brett Leav, Rolando Pajon, Baoyu Ding, Kashif Ali, Gary Berman, Maria Coronado-Voges, Honghong Zhou, Jacqueline M. Miller
Publikováno v:
The New England Journal of Medicine
Background The incidence of coronavirus disease 2019 (Covid-19) among adolescents between 12 and 17 years of age was approximately 900 per 100,000 population from April 1 through June 11, 2021. The safety, immunogenicity, and efficacy of the mRNA-127
Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for Migraine
Autor:
Gary Berman, Philip Halverson, Vladimir Coric, Richard B. Lipton, David Kudrow, Meghan Lovegren, Robert Croop, Charles M. Conway, Alexandra Thiry
Publikováno v:
Headache
Objective Evaluate the safety and tolerability of oral rimegepant when used for acute treatment concomitantly with a monoclonal antibody (mAb) targeting the calcitonin gene-related peptide (CGRP) ligand or receptor (CGRP mAb) for the preventive treat
Publikováno v:
Medico-Legal Journal. 87:130-132
Torus palatinus (TP) is a benign, bony outgrowth located on the hard palate. Variation in this trait occurs, ranging from absent to a protuberance several millimeters in length. If a TP becomes too large, it can interfere with daily activities and th
Autor:
Mary Anne Elder, Ye Tan, Gary Berman, Dmitri Volfson, Julie Brevard, Martin M. Bednar, Adam Ogden, Barbara Evans
Publikováno v:
Annals of Allergy, Asthma & Immunology. 117:433-435
Publikováno v:
Annals of Allergy, Asthma & Immunology. 122:630-638.e3
GSP301 nasal spray is a fixed-dose combination of olopatadine hydrochloride (antihistamine) and mometasone furoate (corticosteroid).To evaluate the efficacy and safety of GSP301 in patients with seasonal allergic rhinitis (SAR).In this double-blind s
Autor:
Julie, Brevard, Mary Anne, Elder, Gary, Berman, Ye, Tan, Dmitri, Volfson, Adam, Ogden, Barbara, Evans, Martin M, Bednar
Publikováno v:
Annals of allergy, asthmaimmunology : official publication of the American College of Allergy, Asthma,Immunology. 117(4)
Publikováno v:
Annals of Allergy, Asthma & Immunology. 121:S60
Introduction Seasonal allergic rhinitis (SAR) symptoms often impair quality of life (QoL). In two randomized, double-blind phase 3 studies, twice-daily GSP301 nasal spray, a fixed-dose combination of olopatadine hydrochloride/mometasone furoate, sign
Autor:
Paul L. Durham, William R. Lumry, Michael Setzen, Howard L. Levine, Gary Berman, Curtis P. Schreiber, David W. Dodick, Eric J. Eross, Harvey J. Blumenthal, Roger Cady
Publikováno v:
Otolaryngology–Head and Neck Surgery. 134:516-523
While "sinus" headache is a widely accepted clinical diagnosis, many medical specialists consider it to be an uncommon cause of recurrent headaches. Unnecessary diagnostic studies, surgical interventions, and medical treatments are often the result o